Brief: Cytotools strengthens unit DermaTools Biotech GmbH through capital increase
Feb 3 (Reuters) - CytoTools AG T5OG.DE :
* Strengthens subsidiary DermaTools Biotech GmbH through a
capital increase
* DermaTools Biotech GmbH receives about 1 million euro ($1
million) of fresh capital
* Funds to be used to prepare and repeat phase III trial in
europe for treatment of diabetic foot
Source text for Eikon: ID:nEQ5HXmsqa
Further company coverage: T5OG.DE
($1 = 0.9152 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 698 39 20;))
Recent news on bioXXmed AG
See all newsBrief: CytoTools Announces Completion Of Capital Increase
Brief: CytoTools - Disputes Between CytoTools, DermaTools, Shareholders Ended
Brief: CytoTools Announces Retirement Of Two Members Of Management Board
Brief: CytoTools Sees Complete Change Of Management Board And Supervisory Board Possible
Lordstown Motors says hedge fund may buy up to $400 mln of its stock (updated)